Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Shanghai OPM Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	741.68	891.14	1,282	1,506	310.34	309.19
Short-Term Investments	-	86.14	52.64	40.07	40.17	-
Trading Asset Securities	319.4	358.08	148.75	170.71	-	-
Cash & Short-Term Investments	1,061	1,335	1,484	1,717	350.51	309.19
Cash Growth	-23.16%	-9.99%	-13.57%	389.76%	13.37%	1066.22%
Accounts Receivable	102.25	110.85	96.35	76.81	41.75	39.3
Other Receivables	26.34	8.57	-	8.04	-	-
Receivables	128.59	119.42	96.35	84.85	41.75	39.3
Inventory	78	59.12	49.21	44.01	33.72	12.54
Prepaid Expenses	-	-	-	10.55	-	-
Other Current Assets	344.38	35.18	30.17	12.66	15.2	10.32
Total Current Assets	1,612	1,549	1,659	1,869	441.18	371.35
Property, Plant & Equipment	350.65	376.42	296.92	264.04	142.83	94.71
Long-Term Investments	109.22	264.58	239.73	143.73	68.09	70.08
Other Intangible Assets	35.92	37.68	39.21	40.33	42.46	-
Long-Term Deferred Tax Assets	9.22	3.58	2.08	0.84	0.13	-
Long-Term Deferred Charges	52.61	52.06	60.3	21.52	25.38	8.92
Other Long-Term Assets	102.45	2.84	4.43	8.53	27	8.01
Total Assets	2,272	2,286	2,302	2,348	747.08	553.07
Accounts Payable	30.22	62.8	37.46	21.31	13.75	11.33
Accrued Expenses	13.69	19.58	18.08	19.91	15.66	5.04
Short-Term Debt	-	-	-	20.02	40.04	15.02
Current Portion of Long-Term Debt	13.77	-	-	4.31	2.13	1.88
Current Portion of Leases	-	13.02	8.6	6.45	5.27	-
Current Income Taxes Payable	15.11	4.42	0.62	-	1.63	-
Current Unearned Revenue	10.75	15.57	4.28	16.04	16.62	1.41
Other Current Liabilities	15.62	4.03	1.6	1.21	0.72	2.34
Total Current Liabilities	99.16	119.42	70.65	89.26	95.82	37.02
Long-Term Debt	-	-	-	10.86	17.77	17.05
Long-Term Leases	44.9	52.32	60.79	50.15	56.51	-
Long-Term Unearned Revenue	27.69	17.89	12.18	12.54	14.53	5.02
Long-Term Deferred Tax Liabilities	0.81	1.33	0.59	0.26	-	-
Total Liabilities	172.55	190.97	144.21	163.07	184.62	59.08
Common Stock	113.55	114.77	114.77	81.98	61.49	61.49
Additional Paid-In Capital	1,858	1,904	1,899	1,925	428.34	420.27
Retained Earnings	129.18	128.58	158.74	178	72.63	12.23
Treasury Stock	-	-51	-13.75	-	-	-
Comprehensive Income & Other	0.24	0.24	0.19	0.12	-	-
Total Common Equity	2,101	2,097	2,159	2,185	562.45	493.99
Minority Interest	-1.84	-1.47	-0.78	-	-	-
Shareholders' Equity	2,100	2,095	2,158	2,185	562.45	493.99
Total Liabilities & Equity	2,272	2,286	2,302	2,348	747.08	553.07
Total Debt	58.66	65.34	69.39	91.8	121.72	33.95
Net Cash (Debt)	1,002	1,270	1,414	1,625	228.79	275.24
Net Cash Growth	-23.69%	-10.20%	-12.96%	610.20%	-16.88%	-
Net Cash Per Share	8.49	10.86	12.30	16.04	2.65	3.20
Filing Date Shares Outstanding	109.43	113.55	113.91	114.77	86.08	86.08
Total Common Shares Outstanding	109.43	113.55	114.53	114.77	86.08	86.08
Working Capital	1,513	1,430	1,589	1,780	345.36	334.33
Book Value Per Share	19.20	18.47	18.85	19.03	6.53	5.74
Tangible Book Value	2,065	2,059	2,119	2,144	519.99	493.99
Tangible Book Value Per Share	18.87	18.13	18.51	18.68	6.04	5.74
Buildings	-	63.8	63.8	63.8	27.17	-
Machinery	-	230.6	200.88	128.56	112.33	-
Construction In Progress	-	169.33	78.1	103.47	1.31	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.